Controlled release effervescent buccal discs of buspirone hydrochloride: in vitro and in vivo evaluation studies

References

• Abu-Huwaij R, Obaidat R, Sweidan K, Al-Hiari Y. (2011). Formulation and in vitro evaluation of xanthan gum or carbopol 934-based mucoadhesive patches, loaded with nicotine. AAPS Pharm Sci Tech 12:21–7
   PubMed Web of Science ®Google Scholar
• Alkhatib HS, Aiedeh KM, Bustanji Y, et al. (2008). Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release. Eur J Pharm Biopharm 70:804–12
   PubMed Web of Science ®Google Scholar
• Asare-Addo K, Conway BR, Larhrib H, et al. (2013). The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices. Colloids Surf B 111:384–91
   PubMed Web of Science ®Google Scholar
• Ayensu I, Mitchell JC, Boateng JS. (2012). Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa. Colloids Surf B Biointerfaces 91:258–65
   PubMed Web of Science ®Google Scholar
• Baveja SK, Ranga Rao KV, Singh A, Gombar VK. (1988). Release characteristics of some bronchodilators from compressed hydrophilic polymeric matrices and their correlation with molecular geometry. Int J Pharm 41:55–62
   Web of Science ®Google Scholar
• Boyapally H, Nukala RK, Bhujbal P, Douroumis D. (2010). Controlled release from directly compressible theophylline buccal tablets. Colloids Surf B 77:227–33
   PubMed Web of Science ®Google Scholar
• Bueno VB, Bentini R, Catalani LH, Petri DFS. (2013). Synthesis and swelling behavior of xanthan-based hydrogels. Carbohydr Polym 92:1091–9
   PubMed Web of Science ®Google Scholar
• Charde S, Mudgal M, Kumar L, Saha R. (2008). Development and evaluation of buccoadhesive controlled release tablets of lercanidipine. AAPS PharmSciTech 9:182–90
   PubMed Web of Science ®Google Scholar
• Chen YY, Hughes LP, Gladden LF, Mantle MD. (2010). Quantitative ultra-fast MRI of HPMC swelling and dissolution. J Pharm Sci 99:3462–72
   PubMed Web of Science ®Google Scholar
• Choi H-G, Jung J-H, Yong CS, et al. (2000). Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. J Control Release 68:405–12
   PubMed Web of Science ®Google Scholar
• Choi H-G, Kim C-K. (2000). Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. J Control Release 68:397–404
   PubMed Web of Science ®Google Scholar
• Darwish M, Kirby M, Robertson Jr P, et al. (2006a). Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100 200:400, and 800 μg in healthy adult volunteers. Clin Ther 28:707–14
   PubMed Web of Science ®Google Scholar
• Darwish M, Tempero K, Kirby M, Thompson J. (2006b). Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus Oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 μg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers. Clin Ther 28:715–24
   PubMed Web of Science ®Google Scholar
• Das N, Madan P, Lin S. (2012). Statistical optimization of insulin-loaded Pluronic F-127 gels for buccal delivery of basal insulin. Pharm Dev Technol 17:363–74
   PubMed Web of Science ®Google Scholar
• Eichman JD, Robinson JR. (1998). Mechanistic studies on effervescent-induced permeability enhancement. Pharm Res 15:925–30
   PubMed Web of Science ®Google Scholar
• El-Samaligy MS, Yahia SA, Basalious EB. (2004). Formulation and evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm 286:27–39
   PubMed Web of Science ®Google Scholar
• Eouani C, Piccerelle P, Prinderre P, et al. (2001). In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur J Pharm Biopharm 52:45–55
   PubMed Web of Science ®Google Scholar
• Espinoza R, Hong E, Villafuerte L. (2000). Influence of admixed citric acid on the release profile of pelanserin hydrochloride from HPMC matrix tablets. Int J Pharm 201:165–73
   PubMed Web of Science ®Google Scholar
• Gohel MC, Parikh RK, Aghara PY, et al. (2009). Application of Simplex Lattice Design and Desirability Function for the Formulation Development of Mouth Dissolving Film of Salbutamol Sulphate. Curr Drug Deliv 6:486–94
   PubMedGoogle Scholar
• Govindasamy P, Kesavan BR, Narasimha JK. (2013). Formulation of unidirectional release buccal patches of carbamazepine and study of permeation through porcine buccal mucosa. Asian Pac J Trop Biomed 3:995–1002
   PubMedGoogle Scholar
• Han R-Y, Fang J-Y, Sung KC, Hu OYP. (1999). Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm 177:201–9
   PubMed Web of Science ®Google Scholar
• Hussain MA, Aungst BJ, Kearney A, Shefter E. (1987). Buccal and oral bioavailability of naloxone and naltrexone in rats. Int J Pharm 36:127–30
   Web of Science ®Google Scholar
• Jaipal A, Pandey MM, Abhishek A, et al. (2013). Interaction of calcium sulfate with xanthan gum: effect on in vitro bioadhesion and drug release behavior from xanthan gum based buccal discs of buspirone. Colloids Surf B Biointerfaces 111C:644–50
   Web of Science ®Google Scholar
• Kanjanabat S, Pongjanyakul T. (2011). Preparation and characterization of nicotine-magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery. AAPS PharmSciTech 12:683–92
   PubMed Web of Science ®Google Scholar
• Kaur A, Kaur G. (2012). Mucoadhesive buccal patches based on interpolymer complexes of chitosan-pectin for delivery of carvedilol. Saudi Pharm J 20:21–7
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. (1983a). Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci 72:1189–91
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. (1983b). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
   Web of Science ®Google Scholar
• Lee J, Kellaway IW. (2000). Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-Ala2, D-Leu5]enkephalin from a cubic phase of glyceryl monooleate. Int J Pharm 204:137–44
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Kivisto KT, Backman JT, et al. (1998). Grapefruit juice substantially increases plasma concentrations of buspirone [ast]. Clin Pharmacol Ther 64:655–60
   PubMed Web of Science ®Google Scholar
• Loane C, Politis M. (2012). Buspirone: what is it all about? Brain Res 1461:111–18
   PubMed Web of Science ®Google Scholar
• Mahmood I, Sahajwalla C. (1999). Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 36:277–87
   PubMed Web of Science ®Google Scholar
• Martínez González I, Villafuerte Robles L. (2003). Influence of enteric citric acid on the release profile of 4-aminopyridine from HPMC matrix tablets. Int J Pharm 251:183–93
   PubMedGoogle Scholar
• Nicolazzo JA, Reed BL, Finnin BC. (2005a). Buccal penetration enhancers—how do they really work? J Control Release 105:1–15
   PubMed Web of Science ®Google Scholar
• Nicolazzo JA, Reed BL, Finnin BC. (2005b). Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release 105:240–8
   PubMed Web of Science ®Google Scholar
• Oh D-H, Chun K-H, Jeon S-O, et al. (2011). Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation. Eur J Pharm Biopharm 79:357–63
   PubMed Web of Science ®Google Scholar
• Ortiz A, Pohl R, Gershon S. (1987). Azaspirodecanediones in generalized anxiety disorder: buspirone. J Affect Disord 13:131–43
   PubMed Web of Science ®Google Scholar
• Pajander J, Baldursdottir S, Rantanen J, Østergaard J. (2012). Behaviour of HPMC compacts investigated using UV-imaging. Int J Pharm 427:345–53
   PubMed Web of Science ®Google Scholar
• Pygall SR, Kujawinski S, Timmins P, Melia CD. (2009). Mechanisms of drug release in citrate buffered HPMC matrices. Int J Pharm 370:110–20
   PubMed Web of Science ®Google Scholar
• Sadeghi AMM, Avadi MR, Ejtemaimehr S, et al. (2009). Development of a Gas Empowered Drug Delivery system for peptide delivery in the small intestine. J Control Release 134:11–17
   PubMed Web of Science ®Google Scholar
• Sander C, Nielsen HM, Jacobsen J. (2013). Buccal delivery of metformin: TR146 cell culture model evaluating the use of bioadhesive chitosan discs for drug permeability enhancement. Int J Pharm 458:254–61
   PubMed Web of Science ®Google Scholar
• Şenel S, Çapan Y, Sargon MF, et al. (1998). Histological and bioadhesion studies on buccal bioadhesive tablets containing a penetration enhancer sodium glycodeoxycholate. Int J Pharm 170:239–45
   Web of Science ®Google Scholar
• Şenel S, Çapan Y, Sargon MF, et al. (1997). Enhancement of transbuccal permeation of morphine sulfate by sodium glycodeoxycholate in vitro. J Control Release 45:153–62
   Web of Science ®Google Scholar
• Şenel S, Hıncal AA. (2001). Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release 72:133–44
   PubMed Web of Science ®Google Scholar
• Sramek JJ, Frackiewicz EJ, Cutlet NR. (1997). Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety. Clin Ther 19:498–506
   PubMed Web of Science ®Google Scholar
• Sramek JJ, Zarotsky V, Cutler NR. (2002). Generalised anxiety disorder: treatment options. Drugs 62:1635–48
   PubMed Web of Science ®Google Scholar
• Sudhakar Y, Kuotsu K, Bandyopadhyay AK. (2006). Buccal bioadhesive drug delivery — a promising option for orally less efficient drugs. J Control Release 114:15–40
   PubMed Web of Science ®Google Scholar
• Tadros MI. (2010). Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro–in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm 74:332–9
   PubMed Web of Science ®Google Scholar
• Tajarobi F, Abrahmsén-Alami S, Carlsson AS, Larsson A. (2009). Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging—effect of solubility of additives on HPMC matrix tablets. Eur J Pharm Sci 37:89–97
   PubMed Web of Science ®Google Scholar
• Tsutsumi K, Obata Y, Takayama K, et al. (1998). Effect of the cod-liver oil extract on the buccal permeation of ionized and nonionized forms of ergotamine using the keratinized epithelial-free membrane of hamster cheek pouch mucosa. Int J Pharm 174:151–6
   Web of Science ®Google Scholar
• Veuillez F, Rieg FF, Guy RH, et al. (2002). Permeation of a myristoylated dipeptide across the buccal mucosa: topological distribution and evaluation of tissue integrity. Int J Pharm 231:1–9
   PubMed Web of Science ®Google Scholar
• Wang L, Tang X. (2008). A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and in vivo evaluation. Int J Pharm 350:181–7
   PubMed Web of Science ®Google Scholar
• Wong CF, Yuen KH, Peh KK. (1999). An in-vitro method for buccal adhesion studies: importance of instrument variables. Int J Pharm 180:47–57
   PubMed Web of Science ®Google Scholar
• Yehia S, El-Gazayerly O, Basalious E. (2008). Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: relationship between swelling, erosion, and drug release. AAPS PharmSciTech 9:1207–17
   PubMed Web of Science ®Google Scholar